Literature DB >> 27533350

Progressive Brain Atrophy in Super-refractory Status Epilepticus.

Sara Hocker1, Elanagan Nagarajan1, Alejandro A Rabinstein1, Dennis Hanson2, Jeffrey W Britton1.   

Abstract

IMPORTANCE: Prolonged seizures in super-refractory status epilepticus (SRSE) have been shown to cause neuronal death and reorganization, and visual inspection in individual case studies has demonstrated progressive cortical and subcortical atrophy. At present, magnetic resonance imaging (MRI) studies that evaluate brain atrophy in SRSE are lacking.
OBJECTIVES: To document and quantify the development of atrophy over time in SRSE. DESIGN, SETTING, AND PARTICIPANTS: This retrospective medical record review included all patients with SRSE who were admitted to a tertiary referral campus of the Mayo Clinic Hospital with SRSE from January 1, 2001, to December 31, 2013. Patients with (1) an initial MRI scan performed within 2 weeks of SRSE onset, (2) a second MRI scan within 6 months of SRSE resolution, and (3) a minimum duration of 1 week between MRI scans were included. The ventricular brain ratio (VBR) was measured on T2-weighted fluid-attenuated inversion recovery (FLAIR) images at disease onset and during follow-up. Measurements were performed on axial FLAIR images with section thickness of less than 5 mm. The plane immediately superior to the caudate head was chosen for analysis. The hypothesis that atrophy develops during SRSE despite seizure control (electroencephalogram background suppression with anesthetic drugs) was tested. Data were analyzed from June 1 to December 31, 2015. MAIN OUTCOMES AND MEASURES: Change in VBR (ΔVBR) as a percentage of the starting measure.
RESULTS: Nineteen patients met the inclusion criteria; these included 10 men (53%) and 9 women (47%) with a median age of 41 (interquartile range [IQR], 25-68) years. Anesthetic agents were required for a median of 13 (IQR, 5-37) days. Initial MRI was performed a median of 2 (IQR, 1-7.5) days from the onset of SRSE, and the second MRI was performed a median of 11 (IQR, 5-15.5) days from the resolution of SRSE, with a median of 40 (IQR, 15-65) days between MRI scans. Median ΔVBR was 23.3% (IQR, 10.5%-70.3%). A significant correlation between the duration of anesthetic agent use and ΔVBR was found (Spearman r = 0.54; P = .02). CONCLUSIONS AND RELEVANCE: Atrophy developed in all patients with SRSE who underwent serial imaging, despite administration of agents for seizure control. The degree of atrophy appears to be related to the duration of SRSE.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27533350     DOI: 10.1001/jamaneurol.2016.1572

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  14 in total

1.  Anesthetics and Outcome in Status Epilepticus: A Matched Two-Center Cohort Study.

Authors:  Raoul Sutter; Gian Marco De Marchis; Saskia Semmlack; Peter Fuhr; Stephan Rüegg; Stephan Marsch; Wendy C Ziai; Peter W Kaplan
Journal:  CNS Drugs       Date:  2017-01       Impact factor: 5.749

2.  Rapidly progressive global cerebral atrophy in the setting of anti-LGI1 encephalitis.

Authors:  Anudeep Yelam; Elanagan Nagarajan; Pradeep C Bollu
Journal:  BMJ Case Rep       Date:  2019-05-24

3.  Power spectrum analysis and outcomes of non-convulsive status epilepticus: a single-center study.

Authors:  Jianhua Chen; Liri Jin; Xiangqin Zhou; Qiang Lu; Qing Liu; Yan Huang
Journal:  Neurol Sci       Date:  2022-09-30       Impact factor: 3.830

Review 4.  Status epilepticus - time is brain and treatment considerations.

Authors:  Caroline Der-Nigoghossian; Clio Rubinos; Ayham Alkhachroum; Jan Claassen
Journal:  Curr Opin Crit Care       Date:  2019-12       Impact factor: 3.687

5.  Early progression of brain atrophy in patients with anti-N-methyl-D-aspartate receptor encephalitis: Case reports.

Authors:  Hiroshi Kataoka; Nobuhiro Sawa; Yasuyo Tonomura; Satoshi Ueno
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

6.  Evolution of Cerebral Atrophy in a Patient with Super Refractory Status Epilepticus Treated with Barbiturate Coma.

Authors:  Christopher R Newey; Pravin George; Premkumar Nattanmai; Christine Ahrens; Stephen Hantus; Aarti Sarwal
Journal:  Case Rep Neurol Med       Date:  2017-01-15

7.  Cryptogenic NORSE: Its distinctive clinical features and response to immunotherapy.

Authors:  Takahiro Iizuka; Naomi Kanazawa; Juntaro Kaneko; Naomi Tominaga; Yutaka Nonoda; Atsuko Hara; Yuya Onozawa; Hiroki Asari; Takashi Hata; Junya Kaneko; Kenji Yoshida; Yoshihiro Sugiura; Yoshikazu Ugawa; Masashi Watanabe; Hitomi Tomita; Arifumi Kosakai; Atsushi Kaneko; Daisuke Ishima; Eiji Kitamura; Kazutoshi Nishiyama
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-09-25

8.  Successful Treatment of Super-Refractory Status Epilepticus with High-Intensity Electroconvulsive Therapy - A Case Report and Review of the Current Literature.

Authors:  Hanna Schneegans; Henning Stetefeld; Christian Dohmen; Oezguer A Onur; Fritz-Georg Lehnhardt
Journal:  J Epilepsy Res       Date:  2019-06-30

9.  Brain structural changes in patients with cardio-facio-cutaneous syndrome: effects of BRAF gene mutation and epilepsy on brain development. A case-control study by quantitative magnetic resonance imaging.

Authors:  Rosalinda Calandrelli; Fabio Pilato; Marco Panfili; Domenica Battaglia; Maria Luigia Gambardella; Cesare Colosimo
Journal:  Neuroradiology       Date:  2021-07-26       Impact factor: 2.804

10.  Comparison of volume of the forebrain, subarachnoid space and lateral ventricles between dogs with idiopathic epilepsy and controls using a stereological approach: Cavalieri's principle.

Authors:  Fraje Watson; A Augusto Coppi; Holger A Volk; Rowena M A Packer; Anna Tauro; Clare Rusbridge
Journal:  Canine Med Genet       Date:  2021-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.